United States · Biotechnology startup

Laronde

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Funding reportedLast round: Series B

BiotechnologyCambridge, United States

What company datasets say Laronde raised

Funding, as reported

Reported in all$490Min dollars
Rounds2
Last roundSeries B
Last round dateAug 2021
Investors listed8

On a portfolio page

Investors who name them

Each firm lists Laronde on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Laronde in front of investors. Or tell us what we have wrong.

List your startupSend a correction